Search research articles
Contact Us
Filters
Showing results (91-100 of 112) with videos related to
Page
of 12
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
December 18, 2018
Early Toxicity of a Phase 2 Trial of Combined Salvage Radiation Therapy and Hormone Therapy in Oligometastatic Pelvic Node Relapses of Prostate Cancer (OLIGOPELVIS GETUG P07)
Loig Vaugier, Clément Palpacuer, Emmanuel Rio, et al.
European Urology Oncology
|
February 8, 2023
The Safety and Efficacy of Salvage Stereotactic Radiation Therapy in Patients with Intraprostatic Tumor Recurrence After Previous External Radiation Therapy: Phase 1 Results from the GETUG-AFU 31 Study
David Pasquier, Thomas Lacornerie, Stéphane Supiot, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
February 5, 2024
Cost-effectiveness of weekly adaptive radiotherapy versus standard IMRT in head and neck cancer alongside the ARTIX trial
Lionel Perrier, Frédéric Balusson, Magali Morelle, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 26, 2022
Afatinib maintenance therapy following post-operative radiochemotherapy in head and neck squamous cell carcinoma: Results from the phase III randomised double-blind placebo-controlled study BIB2992ORL (GORTEC 2010-02)
Séverine Racadot, Isabelle Thennevet, Yaelle Ouldbey, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 3, 2004
The GETUG 70 Gy vs. 80 Gy randomized trial for localized prostate cancer: feasibility and acute toxicity
Véronique Beckendorf, Stéphane Guérif, Elisabeth Le Prisé, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
February 9, 2025
Radiotherapy quality assurance for the PEACE 1 trial: An individual case review analysis
Najlaa Alyamani, Enrico Clementel, Paul Sargos, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 15, 2010
70 Gy versus 80 Gy in localized prostate cancer: 5-year results of GETUG 06 randomized trial
Véronique Beckendorf, Stéphane Guerif, Elisabeth Le Prisé, et al.
Critical Reviews in Oncology/Hematology
|
March 28, 2022
Highly hypofractionated schedules for localized prostate cancer: Recommendations of the GETUG radiation oncology group
Ariane Lapierre, Christophe Hennequin, Amandine Beneux, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 12, 2024
Prognostic Impact of Prostate-Specific Antigen at 6 Months After Radiotherapy in Localized Prostate Cancer: An Individual Patient Data Analysis of Randomized Trials
Lucia Kwak, Praful Ravi, John G Armstrong, et al.
British Journal of Cancer
|
January 6, 2024
Management of non-metastatic anal cancer in the elderly: ancillary study of the French multicenter prospective cohort FFCD-ANABASE
Claire Gouriou, Claire Lemanski, Pascal Pommier, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 112) with videos related to
Sort By:
Page
of 12
International Journal of Radiation Oncology, Biology, Physics
|
December 18, 2018
Early Toxicity of a Phase 2 Trial of Combined Salvage Radiation Therapy and Hormone Therapy in Oligometastatic Pelvic Node Relapses of Prostate Cancer (OLIGOPELVIS GETUG P07)
Loig Vaugier, Clément Palpacuer, Emmanuel Rio, et al.
European Urology Oncology
|
February 8, 2023
The Safety and Efficacy of Salvage Stereotactic Radiation Therapy in Patients with Intraprostatic Tumor Recurrence After Previous External Radiation Therapy: Phase 1 Results from the GETUG-AFU 31 Study
David Pasquier, Thomas Lacornerie, Stéphane Supiot, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
February 5, 2024
Cost-effectiveness of weekly adaptive radiotherapy versus standard IMRT in head and neck cancer alongside the ARTIX trial
Lionel Perrier, Frédéric Balusson, Magali Morelle, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 26, 2022
Afatinib maintenance therapy following post-operative radiochemotherapy in head and neck squamous cell carcinoma: Results from the phase III randomised double-blind placebo-controlled study BIB2992ORL (GORTEC 2010-02)
Séverine Racadot, Isabelle Thennevet, Yaelle Ouldbey, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 3, 2004
The GETUG 70 Gy vs. 80 Gy randomized trial for localized prostate cancer: feasibility and acute toxicity
Véronique Beckendorf, Stéphane Guérif, Elisabeth Le Prisé, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
February 9, 2025
Radiotherapy quality assurance for the PEACE 1 trial: An individual case review analysis
Najlaa Alyamani, Enrico Clementel, Paul Sargos, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 15, 2010
70 Gy versus 80 Gy in localized prostate cancer: 5-year results of GETUG 06 randomized trial
Véronique Beckendorf, Stéphane Guerif, Elisabeth Le Prisé, et al.
Critical Reviews in Oncology/Hematology
|
March 28, 2022
Highly hypofractionated schedules for localized prostate cancer: Recommendations of the GETUG radiation oncology group
Ariane Lapierre, Christophe Hennequin, Amandine Beneux, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 12, 2024
Prognostic Impact of Prostate-Specific Antigen at 6 Months After Radiotherapy in Localized Prostate Cancer: An Individual Patient Data Analysis of Randomized Trials
Lucia Kwak, Praful Ravi, John G Armstrong, et al.
British Journal of Cancer
|
January 6, 2024
Management of non-metastatic anal cancer in the elderly: ancillary study of the French multicenter prospective cohort FFCD-ANABASE
Claire Gouriou, Claire Lemanski, Pascal Pommier, et al.
Page
of 12